Skip to main content
. 2014 Sep 16;9(9):e107181. doi: 10.1371/journal.pone.0107181

Table 2. Characteristics and outcome of patients with severe sepsis.

Variables All patients (n = 484) Survivors (n = 322) Non-survivors (n = 162) P Value
Age, median (IQR) 66 (51–77) 62 (47–74) 71 (56–80) <0.001
Male sex 336 (69.4%) 216 (67.1%) 120 (74.1%) 0.115
ICU admission categories
Medical 371 (76.7%) 239 (74.2%) 132 (81.5%) 0.075
Scheduled surgery 39 (8.1%) 27 (8.4%) 12 (7.4%) 0.709
Emergency surgery 74 (15.3%) 56 (17.4%) 18 (11.1%) 0.070
Reasons for ICU admission
Respiratory disease 259 (53.5%) 163 (50.6%) 96 (59.3%) 0.072
Gastrointestinal disease 59 (12.2%) 46 (14.3%) 13 (8.0%) 0.047
Neurological disease 49 (10.1%) 35 (10.9%) 14 (8.6%) 0.443
Cardiovascular disease 46 (9.5%) 27 (8.4%) 19 (11.7%) 0.237
Trauma 34 (7.0%) 28 (8.7%) 6 (3.7%) 0.043
Renal disease 26 (5.4%) 14 (4.3%) 12 (7.4%) 0.159
Miscellaneous 11 (2.3%) 9 (2.8%) 2 (3.7%) 0.277
Comorbidities
No comorbidity 158(32.6%) 119(37.0%) 39(24.1%) 0.004
Hypertension 166(34.3%) 102(31.7%) 64(39.5%) 0.087
Diabetes mellitus 85(17.6%) 53(16.5%) 32(19.8%) 0.369
Coronary artery disease 83(17.1%) 53(16.5%) 30(18.5%) 0.571
COPD 80(16.5%) 48(14.9%) 32(19.8%) 0.176
Cancer 55(11.4%) 27(8.4%) 28(17.3%) 0.004
Hematologic malignancy 10(2.1%) 7(2.2%) 3(1.9%) 1.000
Organ transplantation 9(1.9%) 4(1.2%) 5(3.1%) 0.169
Chronic respiratory failure 73(15.1%) 44(13.7%) 29(17.9%) 0.219
Chronic heart failure 56(11.6%) 23(7.1%) 33(20.4%) <0.001
Immunocompromise 48(9.9%) 25(7.8%) 23(14.2%) 0.025
Chronic renal failure 13(2.7%) 6(1.9%) 7(4.3%) 0.138
Chronic liver dysfunction 11(2.3%) 7(2.2%) 4(2.5%) 1.000
APACHE II, median (IQR) 21(16–27) 18(14–24) 25(19–32) <0.001
SOFA on ICU day1, median (IQR) 7.5(5–10) 7(5–9) 9(6.75–12) <0.001
Complications
Septic shock 119(24.6%) 68(21.1%) 51(31.5%) 0.012
Acute kidney injury 201(41.5%) 119(37.0%) 82(50.6%) 0.004
ARDS 265(54.8%) 150(46.6%) 115(71.0%) <0.001
ICU stay, days, median (IQR) 7(4–15) 7(4–14) 9(4–17) 0.067

APACHE II, Acute Physiology and Chronic Health Evaluation II; ARDS, acute respiratory distress syndrome; COPD, Chronic obstructive pulmonary disease; ICU, Intensive care unit; IQR, interquartile range; SOFA, Sequential Organ Failure Assessment.